RSI low/high Values: [ 25 - 75 ]
* uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AGIO
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Monday for Agios Pharmaceuticals
(Updated on Jul 22, 2024)

Buy candidate since Jul 09, 2024 Gain 11.83% PDF

The Agios Pharmaceuticals stock price gained 2.45% on the last trading day (Monday, 22nd Jul 2024), rising from $46.61 to $47.75. During the last trading day the stock fluctuated 3.49% from a day low at $46.15 to a day high of $47.76. The price has risen in 8 of the last 10 days and is up by 15.93% over the past 2 weeks. Volume fell on the last day by -128 thousand shares and in total, 399 thousand shares were bought and sold for approximately $19.03 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 42.38% during the next 3 months and, with a 90% probability hold a price between $60.04 and $81.91 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AGIO Signals & Forecast

The Agios Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $47.16 and $44.86. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, June 05, 2024, and so far it has fallen -2.21%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Agios Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $45.22 and $43.83. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Agios Pharmaceuticals finds support just below today's level at $45.22. If this is broken, then the next support from accumulated volume will be at $43.83 and $38.81.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.61 between high and low, or 3.49%. For the last week, the stock has had daily average volatility of 3.26%.

Our recommended stop-loss: $45.85 (-3.98%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 38 days ago.)

Trading Expectations (AGIO) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Agios Pharmaceuticals to open at $47.22, and during the day (based on 14 day Average True Range), to move between $45.97 and $49.53, which gives a possible trading interval of +/-$1.78 (+/-3.73%) up or down from last closing price. If Agios Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 7.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $47.80 (0.10%) than the support at $45.22 (5.30%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Agios Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agios Pharmaceuticals stock to perform well in the short-term.

Current score: 3.287 Buy Candidate Unchanged

Predicted Opening Price for Agios Pharmaceuticals of Tuesday, July 23, 2024

Fair opening price July 23, 2024 Current price
$47.22 ( 1.11%) $47.75

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AGIO

Fibonacci Support & Resistance Levels

Level Price
R3 48.83 2.26%
R2 48.21 0.97%
R1 47.84 0.178%
Price 47.75
S1 46.60 -2.40%
S2 46.23 -3.19%
S3 45.61 -4.48%

Accumulated Volume Support & Resistance Levels

Level Price
R3 48.83 2.26%
R2 47.97 0.461%
R1 47.80 0.105%
Price 47.75
S1 45.22 -5.30%
S2 43.83 -8.21%
S3 38.81 -18.72%


What is the symbol for Agios Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Agios Pharmaceuticals is AGIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Agios Pharmaceuticals Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Agios Pharmaceuticals stock to perform well in the short-term.

How to buy Agios Pharmaceuticals Stock?
Agios Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Agios Pharmaceuticals Stock.

What's the current price of Agios Pharmaceuticals Stock?
As of the end of day on the Jul 22, 2024, the price of an Agios Pharmaceuticals (AGIO) share was $47.75.

What is the 52-week high and low for Agios Pharmaceuticals Stock?
The 52-week high for Agios Pharmaceuticals Stock is $49.06 and the 52-week low is $19.80.

What is the market capitalization of Agios Pharmaceuticals Stock?
As of the Jul 22, 2024, the market capitalization of Agios Pharmaceuticals is 2.711B.

When is the next earnings date for Agios Pharmaceuticals?
The upcoming earnings date for Agios Pharmaceuticals is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Agios Pharmaceuticals

Agios Pharmaceuticals Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph... AGIO Profile

Top Fintech Company featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE